HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ProBiotix Capitalizes On EU Monacolins Restriction With CholBiome Extension

Executive Summary

A recent decision by the European Commission provides UK microbiome specialist ProBiotix Health with an opportunity to present its CholBiome extension as an alternative to red yeast rice as a way to “maintain normal blood cholesterol levels.”

You may also be interested in...

EU Restricts Red Yeast Rice Supplements Over Safety Concerns

Restrictions on daily doses and mandatory label warnings now apply to dietary supplements containing monacolins from red yeast rice sold in the EU following long-running safety concerns about the substance.

People On The Move: Appointments At ProBiotix, EMA, Neuraxpharm

A round-up of the latest European industry appointments: ProBiotix Health names Steen Andersen as its first permanent CEO; EMA appoints Steffen Thirstrup as chief medical officer; Neuraxpharm hires former Almirall exec Alfredo Barón to lead its Spanish business.

Get To Know: ‘Medicine Cabinet Staples’ Manufacturer Kobayashi Healthcare Europe

Manufacturing best-selling items like Kool 'n' Soothe cooling sheet, Cura-Heat heat pack and Hothands hand warmer brands in its own facilities means Kobayashi Healthcare Europe can offer “great quality products without breaking the bank,” explains marketing and regulatory manager Richard Noal.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts